View all Oncology Consultations CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resources

PER Pulse™ Recaps
Two PER Pulse™ Recaps presenting key elements of the Oncology Consultations®: Integrating Molecular Testing into the Breast Cancer Treatment Paradigm online CME activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Genomic Health and Foundation Medicine.


Oncology Consultations®: Integrating Molecular Testing into the Breast Cancer Treatment Paradigm


Release Date: September 28, 2015
Expiration Date: September 28, 2016
Media: Internet - based

Activity Overview

This activity is structured using the Oncology Consultation® platform which features audio clips of two breast cancer experts engaging in case-based discussions of patient management and treatment issues. This educational program features two clinical scenarios that touch upon issues of HER2 equivocal status, molecular profiling for adjuvant decision making, emerging molecular assays for assessment of clinical trial eligibility in the metastatic setting, and germline testing in triple-negative breast cancer. Interactive questions are integrated throughout the cases to reinforce learning.

CME Activity Table of Content

  • Introduction
  • Case of ER+, HER2-Equivocal Breast Cancer
  • Case of TNBC in a Woman With a Family History
  • Key Take-Aways

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience

This activity is directed toward medical and surgical oncologists who treat patients with breast cancer. Pathologists, fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals (HCPs) involved in the management of patients with breast cancer will also be invited to participate. 


Educational Objectives

At the conclusion of this activity, you should be better prepared to:

  • Integrate biomarkers, molecular assays, and other risk assessment tools in treatment decision making for breast cancer, when appropriate.
  • Evaluate emerging clinical data regarding biomarkers and prognostic and predictive molecular assays along with evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients.


Faculty, Staff, and Planners' Disclosures

Faculty

Debu Tripathy, MD
Professor of Medicine and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
Disclosure: Grant/Research Support: Genentech/Roche, Pfizer, Puma Inc, Novartis (clinical trial support contracted to the University of Southern California and MD Anderson Cancer Center); Consultant: Eisai, Onco-Plex Diagnostics, Merck, Novartis.
 

Joyce O'Shaughnessy, MD
Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
The US Oncology Network
Dallas, TX
Disclosure: Consultant: Arno Therapeutics, AstraZeneca, Celgene, Corcept Therapeutics, Eisai, Genentech, GlaxoSmithKline, Lilly, J&J, Merrimack, Novartis, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, MedFusion

 

The following individuals have no relevant financial relationships with commercial interests:

The staff of PER®, LLC (Tiffany Fattizzi and Ann C. Lichti, CHCP), Kim Farina, PhD (medical writer), and Margie Schulz (medical reviewer).


Accreditation/Designation of Credit Statement

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Acknowledgment of Commercial Support

This activity is supported by educational grants from Genomic Health and Foundation Medicine.


Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.


Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.


Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise




Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By